Schonfeld Strategic Advisors »

Vanda Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $521k 59k 8.82
2025-03-31 $1.7M 379k 4.59
2024-12-31 $1.3M 271k 4.79
2023-09-30 $96k 22k 4.32
2022-09-30 $494k 50k 9.88
2021-09-30 $172k 10k 17.20
2019-12-31 $235k 14k 16.45
2016-09-30 $719k 43k 16.66

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
AIGH Capital Management
Millennium Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Empire Financial Management Company
Two Sigma Advisers
Two Sigma Investments
Connor, Clark & Lunn Investment Management
Jacobs Levy Equity Management

View all funds holding Vanda Pharmaceuticals